Cancer stem cell drugs target K-ras signaling in a stemness context

Cancer stem cells (CSCs) are considered to be responsible for treatment relapse and have therefore become a major target in cancer research. Salinomycin is the most established CSC inhibitor. However, its primary mechanistic target is still unclear, impeding the discovery of compounds with similar a...

Descripción completa

Detalles Bibliográficos
Autores principales: Najumudeen, A K, Jaiswal, A, Lectez, B, Oetken-Lindholm, C, Guzmán, C, Siljamäki, E, Posada, I M D, Lacey, E, Aittokallio, T, Abankwa, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057041/
https://www.ncbi.nlm.nih.gov/pubmed/26973241
http://dx.doi.org/10.1038/onc.2016.59

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057041/
https://www.ncbi.nlm.nih.gov/pubmed/26973241
http://dx.doi.org/10.1038/onc.2016.59

Ejemplares similares